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Abstract
Introduction: Osteonecrosis of the jaw is associated with defects in 
vascularization and with the use of oral bisphosphonates. Osseous 
exposition and infection may occur. Recommended treatment is 
variable, from antibiotic medication, bony decortication to resections 
of the mandible in severe cases. Reconstruction of mandible, in cases 
of resections is essential for maintaining esthetic profile and adequate 
form and function. Objective: To report a case about the dangers of 
oral bisphosphonates in association with invasive procedures such 
as dental implants Case report: Female patient, 64 years-old, with 
osteonecrosis of the jaw caused by use of oral bisphosphonates after 
rehabilitation with dental implants. She had an edentulous and atrophic 
mandible and poor healthy. After diagnosis, partial resection of the 
jaw was performed together with the reconstruction with titanium 
plate, with no success. Then, iliac bone graft fixed by plates and 
screws was attempted, again with no success. Conclusion: Despite 
of the small number of cases of osteonecrosis associated with oral 
bisphosphonate reported in the literature, a simple implant surgery 
could result in adverse consequences if the use of this medication 
were overlooked in the anamnesis.
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Introduction
Bisphosphonates are nonmetabolized analogues 
of endogenous pyrophosphate that bind strongly to 
the bone mineral, hydroxyapatite, and are capable 
of localizing to bone and inhibiting osteoclastic 
function. The key pharmacological action of 
bisphosphonates in clinical use is inhibition of bone 
resorption. The exact mechanism of action of this 
bisphosphonate-mediated osteoclast inhibition has 
not been completely elucidated. On one hand, it is 
hypothesized that bisphosphonates are released by 
invasive dental treatment, such as tooth extractions 
or implant placement, with possible subsequent 
direct toxicity to the surrounding soft tissue or 
periosteum; on the other hand, evidence supports 
the hypothesis that bisphosphonate associated 
with osteonecrosis of the jaw is a special type of 
osteomyelitis [18, 19, 21]. 
Intravenous bisphosphonates are used to 
reduce bone pain, hypercalcemia of malignancy 
and skeletal complications in patients with multiple 
myeloma, lung, breast, and other cancers. Oral 
bisphosphonates are used to treat systemic 
osteoporosis, Paget’s disease, and osteogenesis 
imperfect [3]. Bisphosphonate medication associated 
with osteonecrosis of the jaw is a current topic 
in the recent papers [8]. Marx [16], in 2003, was 
the first author to report pain and exposure of 
the bone in the mandible and maxilla in patients 
who used bisphosphonates. Researchers estimated 
the incidence of bisphosphonate associated with 
osteonecrosis of the jaw range from 0.8% to 12% 
for patients receiving intravenous formulations 
[3]. In a study made by Lo et al. [12], in 2009, 
the osteonecrosis in patients exposed to oral 
bisphosphonates occurred in 1 of 952 survey 
respondents (minimum prevalence of 1 in 1,537 
of the entire mailed cohort).
The disease classification is divided into 
stages according to characteristics present in the 
people affected. Patients at risk are asymptomatic 
patients with no clear necrotic bone, who have been 
treated with intravenous or oral bisphosphonates. 
It might be considered to have bisphosphonate 
related osteonecrosis of the jaws if 3 characteristics 
are present: 1. Current or earlier treatment 
with a bisphosphonate; 2. Exposed bone in the 
maxillofacial region that has persisted for more 
than 8 weeks; 3. No history of radiation therapy 
of the jaws. Cases of osteonecrosis caused by 
bisphosphonates were divided into stages: Stage 
0 - Patients with no clinical evidence of necrotic 
bone, but with nonspecific symptoms or clinical 
and radiographic findings; Stage 1 - exposed and 
necrotic bone in patients who are asymptomatic and 
have no evidence of infection; Stage 2 - exposed 
and necrotic bone in patients with pain and clinical 
evidence of infection; Stage 3 - exposed and necrotic 
bone in patients with pain, infection, and that 
may present: pathologic fracture, extraoral fistula, 
oral, antral or nasal communication, osteolysis 
extending to the inferior border of the mandible 
or sinus floor [22].
Treatment strategies should be in accordance 
with disease stage. Patients at risk: not requiring 
any treatment, however these patients should 
be informed of the risks, as well as the signs 
and symptoms of this disease process. Stage 0: 
provide symptomatic treatment, and take care of 
other local factors, such as caries and periodontal 
disease. Systemic management can include the use 
of medication for chronic pain and the control of 
infection with antibiotics, when indicated. Stage 1: No 
surgical treatment is indicated, these patients benefit 
from the use of oral antimicrobial rinses, such as 
0.12% chlorhexidine. Stage 2: these patients benefit 
from antibiotic therapy and oral antimicrobial 
rinses. In some refractory cases, patients might 
require combination of antibiotic therapy, long term 
antibiotic maintenance, or a course of intravenous 
antibiotic therapy. Stage 3: these patients benefit 
from debridement, including resection, of all necrotic 
bone, combined with antibiotic therapy, which might 
offer long-term palliation, with resolution of acute 
infection and pain [22].
When it is necessary debridement and resection 
because the loss of mandibular continuity, there is 
significant functional disability, cosmetic deformity, 
and pathological impairment [11]. The need for 
reconstruction of the mandible is obvious, because 
accounts for the patients’ profile and serves as 
a support for the tongue, allowing mastication, 
deglutition, and phonation. However, the mandible 
is difficult to reconstruct. It is not only highly 
contoured and stress bearing, but in oral cavity it 
is covered superficially only by mucosa [6]. Different 
operative techniques are used to reconstruct the 
defects, but every method that was chosen must 
fulfill three main goals: restoration of continuity, 
restoration and maintenance of form and body, and 
restoration of function and esthetics [1].
This paper reports the case of an elderly patient 
who used oral bisphosphonates and developed 
osteonecrosis of the jaw after a dental implant 
surgery, with a poor prognosis of treatment attempts. 
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Case report
A 64-year-old female patient was referred in 
February 2007 to the Oral and Maxillofacial Surgery 
Service, Federal University of Paraná at Curitiba, 
Brazil, with pain in mandible. The patient reported 
she underwent dental implant surgery in the anterior 
region of mandible in 2004, which were later lost. 
In 2005, the patient referred listened some noise 
in her mandible when she was eating, followed by 
pain in this region. From this day on, she searched 
many services, with no success. 
During the anamnesis, the patient mentioned 
the use of Alendronate® for approximately five years 
to treat osteoporosis. At the extraoral examination, 
we observed active suppuration from a fistulous 
tract in the right side of the mental region. The 
region presented with a considerable swelling and 
the patient related pain. At the maximum mouth 
opening, the mandible shifted to the right side. 
At the intraoral examination, the patient had no 
mandibular teeth and she reported not using the 
prosthesis anymore. It was possible to observe 
some exposed osseous sequestration in oral 
cavity. Radiographic examinations showed a mixed 
sclerotic pattern and a fracture in the midline of 
the mandible (figure 1).
Figure 1 – a) Exposed osseous sequestration; b) Initial view: extraoral fistulous tract; c) Initial panoramic radiograph 
showing dental implants
After the incisional biopsy, the diagnosis 
suggested a chronic osteomyelitis of the mandible, 
because of the signs of the chronic inflammation with 
the medullary fibrosis. The use of bisphosphonates 
was associated as a possible cause of osteonecrosis. 
Antibiotic treatment in combination with 
surgical procedures was the protocol treatment 
of the institution. Patient received an antibiotic 
regimen consisting of Cephalexin 500 mg, every six 
hours, for thirty days. Because of the pathological 
condition, midline fracture, edentulous and atrophic 
mandible, and the extension of pathology, the 
treatment of choice was segmental resection of the 
anterior region of mandible and reconstruction with 
titanium bridging plate contoured according to the 
shape of mandible (figure 2). 
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Figure 2 – a) Radiograph showing a mixed sclerotic pattern and a fracture in the midline of the mandible; b) The 
fracture and necrotic area exposed during the surgery; c) Iliac bone graft fixed by plates and screws; d) Immediate 
post-operative radiograph
The patient’s health was poor, she was quite 
thin and needed special care, proper preoperative 
nursing besides psychological consolation. For 
this procedure, the patient was submitted to 
many examinations, mainly because of her weight: 
70.54 pounds. The patient was instructed by the 
nutritionist and endocrinologist and gained 8.81 
pounds before the surgery procedure. 
In April 2007, the surgery was done. An 
extraoral approach was executed. After carefully 
dissection, the mandible was exposed. It was 
possible to observe the line of fracture and infected 
bone around it. In general, margins of at least 10mm 
beyond all clinically clear pathological mass were 
obtained during the surgery. The reconstruction 
plate (Neortho System®, Curitiba-PR/Brazil) was 
modeled, positioned, and fixed to the ends of the 
remaining mandible segments (figure 3). The plate 
was wrapped by muscle. The clinical incision was 
closed at different layers. The specimen was fixed 
in 10% formalin and submitted to microscopic 
evaluation, which confirmed the results obtained 
in the first biopsy. The position of the plate was 
verified with a panoramic radiograph. The patient 
had no shifting in her maximum mouth opening. 
After one week, an intraoral point of exposure of 
the plate on the symphyseal region occurred in 
the same place that infected bone was exposed 
before surgery. Irrigations of the region were made 
with povidine. 
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Figure 3 – a) Resection of the necrotic bone; b) Reconstruction plate after bone debridement; c) Intraoral exposure 
of the plate; d) Immediate post-operative radiograph
In March 2008, one year after surgery, the 
patient presented an extraoral point of active 
suppuration in mental region. She reported moderate 
pain in the right side of the jaw. Antibiotic and 
analgesics were prescribed. The treatment attempts 
were unsuccessful, and eight months later, the 
patient evolves with extraoral exposure of the plate.
A new treatment was planned for the patient, 
together with the plastic surgery team, at two 
surgical times. First, the plate was removed followed 
by debridement of infection by a multidisciplinary 
team composed by plastic surgeon and oral and 
maxillofacial surgeon. Second, a month later, an 
autogenous grafting from the iliac bone was removed 
by the orthopedic medical staff. The block was fixed 
in the jaw with plates Neortho System®. After some 
weeks, exposure of the graft occurred intraorally 
and extraorally with constant drainage point. The 
radiographic examination showed no consolidation 
of the graft, and two screws were lost in the right 
side of the jaw. The surgeons decided to remove 
the graft and no reconstruction was performed at 
that moment. The intraoperative time occurred with 
no intercurrences. In the end of the procedure, 
the anesthesiologist placed a nasogastric tube to 
ensure the nutritional support to the patient. The 
patient had an episode of vomiting and bronchial 
aspiration over the content of the diet, leading to a 
pneumothorax, resulting in multiple organ failure 
and death.
Discussion
Current literature includes only a small number 
of cases of osteonecrosis of the jaw following surgery 
in oral cavity of patients taking oral bisphosphonates 
[21]. The American Dental Association published 
special recommendations about care with placement 
of dental implants or guided bone regeneration that 
involves risk of developing osteonecrosis in patients 
who uses or had taken oral bisphosphonates. The 
recommendations of The American Association 
of Oral and Maxi l lofacia l Surgeons do not 
contraindicate the surgery of dental implants in 
patients who have been taking bisphosphonates 
orally for under three years if their had no other 
risk factors such as medication with corticosteroids 
or advanced age. In cases who the patient has been 
taking the drug for three years, it is recommended 
to cease medication for a minimum of three months 
before any type of surgical intervention, and in the 
case of dental implants, it is recommended to wait 
three months before administrating the drug again 
[5]. Ruggiero et al. [22] also believed that the time 
of taking bisphosphonates was a significant risk 
to osteonecrosis because other factors as systemic/
local features and potency of bisphosphonates 
may raise the incidence rate of the osteonecrosis. 
Shin et al. [23] described that implant treatments 
have increased markedly also in elderly persons. 
The numbers of patients who have been treated 
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with bisphosphonates or continue to use them for 
treatment of osteoporosis is rising. As a result, the 
risk of oral bisphosphonate-related osteonecrosis 
of the jaw increases after implant placement. The 
more powerful potency of bisphosphonates and the 
longer period of taking also increase the chance 
of osteonecrosis.
Fernández et al. [7], in 2009, observed through 
a literature review that six patients had osteonecrosis 
of the jaw caused by bisphosphonates related with 
dental implants: five were women (all over 50 years 
of age); 3 with osteoporosis and 2 with osteopenia. 
One patient was treated with zoledronic acid; 3 
with alendronate, 1 with etidronate disodium and 
another with risedronate.
In other study, 44 dental implants were placed 
(26 patients who had taken bisphosphonates for 
less than 3 years and 18 patients who had taken 
the medication for more than 3 years). Of the 26 
individuals of first group, 7 were associated with 
osteonecrosis of the jaw and 6 implants were lost 
(5 in the jaw); of the last 18 individuals, 14 suffered 
osteonecrosis of the jaw and 4 implants were lost 
(the 4 located in the jaw) [7].
Tam et al. [25], in 2014, present six cases 
of jaw osteonecrosis that might have occurred 
because the patients had taken nitrogen containing 
bisphosphonates via oral and/or intravenous route 
before placing dental implants. Two of these 
patients had taken only oral bisphosphonate and 
the authors state that unusual jaw necrosis after 
dental implants might be related with oral and/
or intravenous bisphosphonates. The authors also 
described that the keys to successful healing are 
wide resection of necrotic bone, collagen graft and 
primary closure. The growth in the number of 
treatments with dental implants has brought also a 
great argumentation in the number of complications 
related with them. Advanced osteomyelitis could 
be fracture of the jaw, mainly if the mandible is 
edentulous and atrophic [28].
The treatment of osteonecrosis of the jaw depends 
on the severity and stage of the osteonecrosis, 
current concepts vary from conservative approaches 
with antimicrobial rinsing and oral antibiotics 
to radical surgery. The concept is characterized 
by surgical resection of the entire necrotic bone 
followed by conscientious smoothening of sharp 
bone edges, and then wound closure [26]. Most of 
resections are immediately reconstructed with a 
rigid titanium plate so that secondary infection is 
controlled; another approach consists of installing 
the plate only after the recipient site has healed 
and is infection free. Bone graft reconstructions 
are rarely needed, but can be also an alternative 
[17]. Madsen and Hang [14] believe that biologic and 
biomechanical problems are associated with elderly 
population. Reduction in blood flow, change in bone 
quality and loss of the buttressing effects associated 
with diminished bone height are examples of these 
modifications. For this reason, it is necessary to 
use special fixation material and techniques in 
atrophic edentulous mandible.
Our treatment of choice was the resection of 
mandibular symphysis followed by reconstruction. 
The decision was based on the history of patient: 
dental implants, osteomyelitis, fracture of atrophic 
and edentulous mandible, and poor systemic 
conditions. The use of rigid internal fixation 
(reconstruction system) increased stability during 
the repair of this surgery reestablishing bone 
continuity, functionality, and esthetics [13, 14].
One of the problems related to reconstruction 
of these plates is the exposure of the plates in 
the oral cavity [2, 4, 10, 13, 15]. Lopez et al. [13] 
affirmed that the correct alternative to solve such 
problems is a new flap.
Hanasono et al. [9] reported that their 
experience following segmental mandibulectomy 
with microvascular free f lap reconstruction in 
patients with advanced osteonecrosis is an effective 
reconstructive option in patients with stage 3. The 
success rate of this treatment is high according to 
the authors, but complications are frequent.
We decided to try a different attempt because 
of persistent exposure and recurrent infections. 
Remove the plate and perform a correct debridement 
of the jaw awaiting proper bone healing and 
stability to realize an autogenous iliac bone graft. 
Unfortunately, after the surgery of autogenous iliac 
bone graft, some signs of non-integration made the 
surgeons remove all the bone graft, but the patient’s 
systemic conditions and an unexpected medical 
complication led the patient to death. 
After the patient’s death, the family reported 
that the patient used to smoke, which was never 
reported. In a study made by Rodriguez-Argueta 
et al. [20], they discussed how the cigarette 
components affected the bone vascularization, the 
nicotine is a potent vasoconstrictor that reduces 
blood flow and nutrient delivery to healing sites, 
causing tissue glucose reduction and acidosis. The 
carbon monoxide also reduces the oxygen-carrying 
capacity of erythrocytes, and hydrogen cyanide 
causes tissue hypoxia [20, 24, 27]. Additionally, 
the very poor systemic health did not allow an 
adequate treatment and she did not respond to 
several attempts.
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Conclusion
Despite of the small number of cases of 
osteonecrosis of the jaw associated with the use of 
oral bisphosphonate after implant surgery reported 
in the literature, the use of this medication should 
be carefully analyzed during the patient’s medical 
history and considered in treatment planning, 
especially when associated with other risk factors. 
The use of bisphosphonate put the individual at 
high risks. In this case report, a simple dental 
implant surgery became a source of weakness for 
the patient. Lack of knowledge about the risk of 
bisphosphonates together with other risk factors 
such as the patient’s poor systemic conditions 
led to years of failed rehabilitation attempts. 
Therefore, a detailed anamnesis, explaining to 
patients the importance of giving correct answers, 
and attention to every medication in use, based on 
scientific evidences, is still the best way to prevent 
complications in dentistry.
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